• A Study of Emrusolmin Safety and Effectiveness in Adults with Multiple System Atrophy, a Brain and Nerve Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain
  • A Study of Povetacicept Compared to Tacrolimus for Adults with Primary Membranous Nephropathy

    Recruiting

    4 1 1
    Investigated Drugs:
    Czechia Germany Hungary Ireland Italy The Netherlands +1
  • A Study of Mirvetuximab Soravtansine, Carboplatin, and Bevacizumab in Adults with Ovarian Cancer

    Recruiting

    2 1 1 1
    Belgium Czechia Denmark France Spain
  • Long-term Safety Study of Vusolimogene Oderparepvec, RP2, and RP3 in Patients with Melanoma, Liver Cancer, or Advanced Solid Tumors

    Recruiting

    3 1 1
    France Germany Greece Poland Spain
  • A Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain
  • A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Hungary Italy Poland Portugal +1
  • Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark France Germany +6
  • A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

    Recruiting

    2 1 1
    Austria Belgium Denmark Finland France Germany +5
  • A Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Czechia France Germany Hungary Italy +2
  • Study Using Fluorescent Adalimumab and Risankizumab to See How These Drugs Work in Patients with Inflammatory Bowel Disease

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

powered by